Drugs Modulating TLR Activity

The review presents characteristics of drugs being developed that modulate Toll-like receptors activity and can be applied in the treatment of infectious, chronic inflammatory, autoimmune, allergic diseases, malignancies.

Bibliographic Details
Main Authors: A.Ye. Abaturov, A.P. Volosovets, Ye.I. Yulish
Format: Article
Language:English
Published: Publishing House Zaslavsky 2014-09-01
Series:Zdorovʹe Rebenka
Subjects:
Online Access:http://childshealth.zaslavsky.com.ua/article/view/75743